Skip to main content

Table 2 The numbers of the case control subjects according to fatty acid quintiles and adjusted odds ratios in the study participants

From: Plasma fatty acids and the risk of metabolic syndrome in ethnic Chinese adults in Taiwan

 

Q1

Q2

  

Q3

  

Q4

  

Q5

  

P, Trend

Saturated fat, % total fatty acids

Range

< 38.0

38.0-40.1

  

40.1-42.5

  

42.5-45.7

  

> = 45.7

   

Median

36.6

39.2

  

41.2

  

44.1

  

48.3

   

Control

195

196

  

196

  

197

  

195

  

< .0001

Cases

127

168

  

221

  

201

  

281

   

Odds ratio

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

 

Model 1

1

1.31

0.97

1.78

1.75

1.30

2.34

1.57

1.16

2.11

2.22

1.66

2.97

< .0001

Model 2

1

1.05

0.67

1.64

1.48

0.97

2.28

1.20

0.78

1.84

1.94

1.27

2.96

0.002

Model 3

1

1.03

0.65

1.63

1.33

0.85

2.06

1.03

0.66

1.60

1.68

1.08

2.62

0.025

MUFA, % total fatty acids

          

Range

< 12.6

12.6-14.1

  

14.1-15.4

  

15.4-16.9

  

> = 16.9

   

Median

11.5

13.5

  

14.7

  

16.2

  

18.2

   

Control

195

196

  

197

  

196

  

195

  

< .0001

Cases

117

150

  

161

  

256

  

314

   

Model 1

1

1.27

0.93

1.74

1.38

1.01

1.89

2.22

1.65

2.99

2.76

2.06

3.70

< .0001

Model 2

1

1.26

0.80

1.99

1.01

0.64

1.59

1.89

1.22

2.91

2.12

1.37

3.26

< .0001

Model 3

1

1.14

0.71

1.83

0.94

0.59

1.51

1.78

1.14

2.80

1.89

1.18

3.01

0.001

Transfat, % total fatty acids

         

Range

< 5.2

5.2-5.9

  

5.9-6.7

  

6.7-7.7

  

> = 7.7

   

Median

4.6

5.5

  

6.3

  

7.2

  

8.7

   

Control

195

197

  

194

  

197

  

196

  

< .0001

Cases

147

147

  

178

  

222

  

303

   

Model 1

1

0.99

0.73

1.34

1.23

0.91

1.65

1.50

1.12

2.00

2.05

1.55

2.72

< .0001

Model 2

1

0.88

0.56

1.37

1.18

0.77

1.83

1.81

1.20

2.75

1.68

1.11

2.53

0.0003

Model 3

1

0.81

0.51

1.29

1.09

0.69

1.72

1.65

1.07

2.54

1.53

0.99

2.35

0.002

N-6 fatty acids, % total fatty acids

      

Range

< 28.7

28.7-31.1

  

31.1-33.3

  

33.3-35.8

  

> = 35.8

   

Median

26.4

29.9

  

32.2

  

34.4

  

37.4

   

Control

195

196

  

196

  

196

  

196

  

< .0001

Cases

363

225

  

181

  

159

  

70

   

Model 1

1

0.62

0.48

0.80

0.50

0.38

0.65

0.43

0.33

0.57

0.19

0.14

0.27

< .0001

Model 2

1

0.83

0.57

1.21

0.65

0.44

0.96

0.55

0.38

0.82

0.31

0.20

0.49

< .0001

Model 3

1

0.84

0.57

1.24

0.69

0.46

1.04

0.64

0.42

0.97

0.36

0.22

0.59

< .0001

EPA, % total fatty acids

        

< .0001

Range

< 0.28

0.28-0.38

  

0.38-0.52

  

0.52-0.76

  

> = 0.76

   

Median

0.22

0.33

  

0.44

  

0.62

  

0.94

   

Control

196

196

  

196

  

196

  

195

   

Cases

299

186

  

185

  

186

  

142

   

Model 1

1

0.62

0.47

0.81

0.60

0.46

0.79

0.60

0.45

0.78

0.46

0.34

0.61

< .0001

Model 2

1

0.61

0.41

0.92

0.51

0.34

0.76

0.67

0.45

0.99

0.51

0.33

0.77

0.013

Model 3

1

0.60

0.39

0.91

0.51

0.34

0.78

0.68

0.45

1.03

0.51

0.33

0.80

0.028

DHA, % total fatty acids

            

Range

< 1.97

1.97-2.45

  

2.45-2.89

  

2.89-3.56

  

> = 3.56

   

Median

1.6

2.2

  

2.7

  

3.2

  

4.0

   

Control

96

196

  

195

  

197

  

195

   

Cases

281

256

  

167

  

161

  

133

   

Model 1

1

0.89

0.69

1.16

0.58

0.44

0.77

0.55

0.42

0.73

0.45

0.34

0.60

< .0001

Model 2

1

0.97

0.66

1.43

0.68

0.45

1.02

0.54

0.36

0.82

0.58

0.38

0.89

0.001

Model 3

1

0.90

0.60

1.34

0.69

0.45

1.05

0.55

0.35

0.85

0.59

0.38

0.92

0.003

  1. Model 1: adjusted for age and gender
  2. Model 2: additional body mass index, smoking, drinking and exercise
  3. Model 3: additional LDL cholesterol, systolic and diastolic blood pressure, uric acid, fasting glucose levels and total fat amount in plasma
  4. Abbreviations see Table 1